CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,875,448 | -52.5% | 322,509 | -41.4% | 0.06% | -53.3% |
Q2 2023 | $18,678,770 | -5.3% | 550,509 | -7.6% | 0.14% | -1.5% |
Q1 2023 | $19,721,491 | -9.4% | 595,509 | +21.9% | 0.14% | -6.8% |
Q4 2022 | $21,771,826 | +85.1% | 488,509 | +16.7% | 0.15% | +77.1% |
Q3 2022 | $11,765,000 | +50.1% | 418,509 | +43.9% | 0.08% | +27.7% |
Q2 2022 | $7,839,000 | -17.1% | 290,794 | +4.8% | 0.06% | +1.6% |
Q1 2022 | $9,451,000 | -36.8% | 277,481 | -28.3% | 0.06% | -32.6% |
Q4 2021 | $14,962,000 | +53.8% | 387,221 | +114.9% | 0.10% | +43.9% |
Q3 2021 | $9,730,000 | -27.2% | 180,222 | -54.9% | 0.07% | -27.5% |
Q2 2021 | $13,365,000 | +130.7% | 399,685 | +16.1% | 0.09% | +89.6% |
Q1 2021 | $5,792,000 | -3.9% | 344,139 | 0.0% | 0.05% | 0.0% |
Q4 2020 | $6,030,000 | – | 344,139 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |